Aeluma (NASDAQ: ALMU) is poised for success due to its critical technology in AI advancement. The company focuses on photonics and compound semiconductors, offering enhanced performance at lower costs. Revenue growth is expected to exceed 300% by 2029, with significant growth projected in 2026 and 2027.

Institutional activity shows optimism with 25% ownership and strong buying momentum. Analysts rate ALMU a Buy with potential for over 70% upside. Securing defense contracts and advancing manufacturing capacity are key catalysts for 2026. Insider selling and short interest pose risks, but a capital raise in 2025 has strengthened the company.

Aeluma’s balance sheet strength helps offset dilution concerns, with over $38 million in cash at the end of fiscal Q1 2026. The company’s prior capital raise increased share count but also improved financial stability. Despite dilution risks, the long-term growth outlook remains positive.

As Aeluma approaches its February earnings report, the stock is trading within a range above a critical support target. Updates on capacity expansion and contract wins are expected to drive the market higher. Failure to meet expectations could lead to a retreat in stock price, potentially falling to $12 before hitting the next support target.

Read more at Nasdaq: Shedding Light on Aeluma’s Stock Price Outlook